UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review

Table 2 Synopsis of recent case reports decribing various phototherapeutic alternatives in a number of sclerotic rarities. [Categories: A – double-blind, randomized, placebo-controlled; B – open, randomised; C – open, non-randomized; D – case series; E – case report]

Disease	Therapy	Dosage	Experience	Comments
Eosinophilic fasciitis	UVA1⁸⁰	low-dose	E	benefit, no valid data available
	PUVA⁸¹	medium-dose	E
Pansclerotic morphea	UVA⁸⁴	low-dose	E	possible efficacy as an adjunct therapy,
	UVA1⁸³	low-dose	E	no valid data available
	PUVA^85,86	medium-dose	E
Scleromyxedema	PUVA^90–92	high-dose	E	controversial, possible efficacy as an adjunct therapy, no valid data available
Scleredema adultorum Buschke	PUVA^95,96	high-dose	E, D	possible therapeutic alternative, cream therapy, no valid data available
POEMS	UVA1⁹⁸	low-dose	E	benefit, no valid data available
Bleomycin-induced scleroderma	UVA1⁹⁹	low-dose	E	limited success, no valid data available
Pansclerotic porphyria cutanea tarda	UVA1¹⁰¹	medium-dose	E	benefit, no valid data available

ISSN: 1471-5945